Literature DB >> 25184058

Nasopharyngeal carcinoma in dermatomyositis patients: A 10-year retrospective review in Hospital Selayang, Malaysia.

J W Teoh1, Razif M Yunus2, Faridah Hassan3, Norazmi Ghazali3, Zainal A Z Abidin3.   

Abstract

AIM: The objective of our review is to investigate the association between dermatomyositis patients and nasopharyngeal carcinoma (NPC) together with the clinical presentation of the patients and their management in otorhinolaryngology.
BACKGROUND: NPC is a malignant disease with good prognosis on early diagnosis. However, the relationship between the dermatomyositis and NPC and its management is not well defined.
MATERIALS AND METHODS: A 10-year retrospective review of case records of 21 dermatomyositis patients seen in Otorhinolaryngology Department of Hospital Selayang from January 2000 to November 2010.
RESULTS: These patients ranged from 19 to 74 years old and a total of 8 (38%) out of 21 adults with dermatomyositis were detected to have malignancy. Five out of 8 patients had NPC (62.5%). The mean age of patients with NPC and dermatomyositis was 48 years. NPC is diagnosed in 4 out of 5 patients (80%) in the first year of diagnosis of dermatomyositis. The clinical findings of the examination of nasopharynx ranged from hyperemia to exophytic nasopharyngeal mass. Histologically, it is only related to NPC of WHO types II and III.
CONCLUSIONS: There is a strong relationship between dermatomyositis and malignancy, especially NPC. Clinicians should have a high index of suspicion for malignancy in all dermatomyositis patients. Rigid nasoendoscopies and biopsies, serum Epstein-Barr viral capsid IgA antibody and imaging studies are helpful in detecting NPC in dermatomyositis patients.

Entities:  

Keywords:  Dermatomyositis; Epstein–Barr viral capsid IgA; Nasopharyngeal carcinoma; Paraneoplastic; WHO histology

Year:  2014        PMID: 25184058      PMCID: PMC4150095          DOI: 10.1016/j.rpor.2014.02.005

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  14 in total

Review 1.  Dermatomyositis.

Authors:  J P Callen
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

2.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

3.  An 11-year review of dermatomyositis in Asian patients.

Authors:  Wen Chun Liu; Madeline Ho; Woon-Puay Koh; Audrey W H Tan; Patricia P L Ng; Sze Hon Chua; Suat Hoon Tan; Mark B Y Tang
Journal:  Ann Acad Med Singapore       Date:  2010-11       Impact factor: 2.473

4.  Dermatomyositis and malignancy in Tunisia: a multicenter national retrospective study of 20 cases.

Authors:  Amel Mebazâa; Hamouda Boussen; Rafiâa Nouira; Lilia Rokbani; Amel Ben Osman-Dhahri; Noureddine Bouaouina; Chedia Laouani-Kechrid; Bessem Louzir; Abdelmajid Zahaf; Mohamed Ridha Kamoun
Journal:  J Am Acad Dermatol       Date:  2003-04       Impact factor: 11.527

5.  Dermatomyositis and cancer in Singapore.

Authors:  H L Chan
Journal:  Int J Dermatol       Date:  1985-09       Impact factor: 2.736

6.  Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder.

Authors:  M L Gulley; M B Amin; J M Nicholls; P M Banks; A G Ayala; J R Srigley; P A Eagan; J Y Ro
Journal:  Hum Pathol       Date:  1995-11       Impact factor: 3.466

7.  Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.

Authors:  Yi-Ju Chen; Chun-Ying Wu; Yu-Lin Huang; Chang-Bi Wang; Jui-Lung Shen; Yun-Ting Chang
Journal:  Arthritis Res Ther       Date:  2010-04-16       Impact factor: 5.156

8.  Nasopharyngeal carcinoma with dermatomyositis. Analysis of 12 cases.

Authors:  J C Peng; T S Sheen; M M Hsu
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-11

Review 9.  Paraneoplastic syndromes in patients with nasopharyngeal cancer.

Authors:  C Toro; A Rinaldo; C E Silver; M Politi; A Ferlito
Journal:  Auris Nasus Larynx       Date:  2008-12-27       Impact factor: 1.863

10.  Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.

Authors:  D Stockton; V R Doherty; D H Brewster
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640

View more
  9 in total

1.  The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma.

Authors:  Chuan Jin; Bingchuan Yan; Qin Lu; Yanmin Lin; Lei Ma
Journal:  Tumour Biol       Date:  2015-10-20

2.  The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma.

Authors:  Yaoyong Lu; Tao Li; Ganbao Wei; Liangbo Liu; Qinsheng Chen; Lufei Xu; Kunqiang Zhang; Dehao Zeng; Rongwei Liao
Journal:  Tumour Biol       Date:  2016-03-28

Review 3.  Pathologic aspects of skull base tumors.

Authors:  Andrzej Marszałek; Łukasz Szylberg; Sławomir Wiśniewski
Journal:  Rep Pract Oncol Radiother       Date:  2016-04-03

4.  Dermatomyositis Associated with Lung Neuroendocrine Carcinoma.

Authors:  Reina Takashima; Kazufumi Takamatsu; Yutaka Shinkawa; Masato Yagita; Motonari Fukui; Masaaki Fujita
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

5.  Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.

Authors:  Jung-Lung Hsu; Ming-Feng Liao; Chun-Che Chu; Hung-Chou Kuo; Rong-Kuo Lyu; Hong-Shiu Chang; Chiung-Mei Chen; Yih-Ru Wu; Kuo-Hsuan Chang; Yi-Ching Weng; Chun-Wei Chang; Hsing-I Chiang; Chih-Kuang Cheng; Pai-Wei Lee; Chin-Chang Huang; Long-Sun Ro
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

6.  A Study on Dermatomyositis and the Relation to Malignancy.

Authors:  Andreea Daniela Tudorancea; Paulina Lucia Ciurea; Ananu Florentin Vreju; Adina Turcu-Stiolica; Cristina Elena Gofita; Cristina Criveanu; Anca Emanuela Musetescu; Stefan Cristian Dinescu
Journal:  Curr Health Sci J       Date:  2021-09-30

Review 7.  Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis.

Authors:  Milena Marzęcka; Anna Niemczyk; Lidia Rudnicka
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-11       Impact factor: 10.817

8.  Dermatomyositis revealing breast cancer: report of a case.

Authors:  Safae Lamquami; Sanae Errarhay; Nisrine Mamouni; Chahrazad Bouchikhi; Abdelaziz Banani
Journal:  Pan Afr Med J       Date:  2015-06-05

9.  Characteristics and predictors of malignancy in dermatomyositis: Analysis of 239 patients from northern China.

Authors:  Ying Liu; Lulu Xu; Hongliang Wu; Na Zhao; Yanchun Tang; Xiaoping Li; Ying Liang
Journal:  Oncol Lett       Date:  2018-09-05       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.